This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Fresnillo PLC | 2,410.0 | 5.8% |
| JD Sports Fashion PLC | 80.4 | 4.4% |
| Metlen Energy & Metals PLC | 42.1 | 4.2% |
| ICG PLC | 2,054.0 | 4.1% |
| Convatec Group PLC | 236.6 | 2.6% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| BAE Systems PLC | 1,724.5 | -4.5% |
| Diageo PLC | 1,702.0 | -4.3% |
| Babcock International Group PLC | 1,118.0 | -3.4% |
| St. James’s Place PLC | 1,260.5 | -3.2% |
| Glencore PLC | 352.9 | -3.0% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 9,507 | 0.5% | 17.4% |
| DOW JONES INDUS. AVG | 46,139 | 0.1% | 6.4% |
| DAX INDEX | 23,163 | 0.1% | 21.5% |
| NIKKEI 225 | 48,538 | 0.3% | 26.6% |
| S&P/ASX 200 INDEX | 8,448 | 0.3% | 1.5% |
| Commodity | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 59.50 | 2.04% |
| Brent Crude (ICE) | USD/bbl. | 63.56 | 2.03% |
| Gold Spot | USD/t oz. | 4,073 | 0.2% |
| Copper (Comex) | USd/lb. | 510 | 0.9% |
The UK 100 is called to open +52 points at 9559. The UK 100 looks set to open higher this morning, having given up a further ground yesterday, global markets found some relief from recent concerns surrounding AI stock valuations.
The S&P rose on Wednesday following a four-day slide centred around technology as investors looked ahead to Nvidia’s earnings. The AI Mega cap Nvidia reported fiscal third-quarter earnings on Wednesday that topped Wall Street expectations for sales and earnings, Nvidia said it expected about $65 billion in sales in the current quarter, versus $1.43 in earnings per share on $61.66 billion of revenue expected by analysts.
The broad market index gained 0.38% to close at 6,642.16, while the Nasdaq advanced 0.59% to settle at 22,564.23. The Dow Jones climbed 47 points, or 0.1%, to finish at 46,138.77. Alphabet was among the winners of the day, rising about 3% and hitting a new all-time high. Shares were rallying around optimism about its new generation of AI, Gemini 3, which it rolled out Tuesday.
Asian markets are mostly higher this morning, with Japan’s Nikkei jumping 2.65% and Korea’s Kospi up 1.9%, while Nasdaq and S&P futures are pointing to increases of 1.8% and 1.3%.
AstraZeneca’s Koselugo (Selumetinib) approved in the US for adults with neurofibromatosis type 1, based on KOMET Phase III trial results showing 20% reduction in tumour response rate. Already approved in EU, Japan, and other countries.
JD Sports Fashion today said annual profits will be towards the lower end of City expectations. The retailer said its guidance reflected “incrementally weaker macro and consumer indicators” heading into its peak trading period. The current City consensus is for a profit of £871 million, with a range of £853 million to £888 million. The company posted a figure of £923 million for 2024/25. A third quarter update showed like-for-like sales 2.4% higher on an organic basis in the 13 weeks to 1 November, boosted by an improved trend in North America. Underlying sales fell 2% in the UK, better than the 4,5% decline in the second quarter.
Johnson Matthey reported strong half-year results, with a 38% increase in pro forma underlying operating profit, despite a 78% decline in reported operating profit due to prior period disposals. The company is progressing with its transformation into a leaner, cash-generative business, with significant improvements in cash flow and a planned return of £1.4 billion to shareholders. The sale of Catalyst Technologies is on track for completion in 2026, and the company expects to achieve its medium-term targets, including growth in operating profit and enhanced shareholder returns.
Mitie Group reported revenue of £2.68 billion for the first half of fiscal 2026 (FY26), up 10.4% year-over-year, supported by 6.4% organic growth from net contract wins, project work and pricing, with acquisitions contributing a further 4%. Operating profit before Other items increased 8% to £109 million, while the margin held broadly steady at 4.1% despite inflation and higher National Insurance costs. Profit before tax, before other items, totalled £98 million in the first six months, up from £94.5 million in the year-ago period. Free cash flow improved to £52 million from £34 million a year earlier, with operating cash flow up sharply to £115 million. Mitie posted record contract awards of £3.8 billion and expanded its order book to £16.5 billion, a 7% increase from the end of the previous financial year. The bidding pipeline grew 39% to £33 billion, with more than 70% of that expected to be awarded within 18 months. Renewal rates were strong at 86%, and the book-to-bill ratio reached 141%. The company reiterated full-year guidance for at least £260 million in operating profit before other items and at least £120 million in free cash flow.
UK
Grainger (GRI)
Investec (INVP)*
Liontrust Asset Management (LIO)
Johnson Matthey (JMAT)
Mitie Group (MTO)
JD Sports Fashion (JD)
Ithaca Energy (ITH)
Halma (HLMA)
LondonMetric Property (LMP)
US
Walmart Inc (WMT) PMO
Intuitive Surgical Inc (ISRG) AMC
UK
ASOS (ASC)
Babcock (BAB)
US
Alibaba Group Holding Ltd ADR (BABA) PMO
PBoC Interest Rate Decision
German Producer Price Index
US Initial Jobless Claims
Philadelphia Fed Manufacturing Survey
EU Consumer Confidence
US Existing Home Sales Change
Fed’s Cook speech
BoE’s Dhingra speech
Fed’s Goolsbee speech
UK 100 companies going ex-dividend on 20th November 2025:
National Grid
Scottish Mortgage Investment Trust
Vodafone
DCC
UK 250 companies going ex-dividend on 20th November 2025:
Volution Group
Empiric Student Proprty
RS Group
Tate & Lyle
Kainos Group
3i Infastructure
B&M European Value Retail
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.